|
Real-time Estimate
Cboe BZX
23:59:55 27/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 37.96 USD | +1.38% |
|
-3.24% | -10.24% |
| 10-12 | UBS Initiates Coverage on Nektar Therapeutics With Neutral Rating, $53 Price Target | MT |
| 10-12 | Leerink Partners Initiates Nektar Therapeutics at Outperform, $130 Price Target | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.38% | -3.24% | -37.17% | -46.81% | -10.24% | -39.35% | +433.98% | -84.11% | -79.35% | 1.28B | |
| -3.10% | -3.43% | -12.88% | +13.18% | +56.09% | +36.29% | +67.69% | +1.93% | - | 65.28B | |
| +0.33% | +0.33% | -7.32% | -0.89% | +9.21% | +10.16% | +78.07% | +225.62% | +5,451.77% | 54.57B | |
| +0.16% | +1.73% | +8.83% | +13.66% | +18.22% | +9.89% | +102.10% | -15.79% | +259.62% | 53.59B | |
| -0.76% | +1.68% | +0.51% | +27.74% | +20.83% | +25.26% | +51.36% | +7.11% | +277.75% | 45.03B | |
| -1.32% | -4.82% | -0.28% | +12.30% | +20.46% | +16.02% | +114.71% | -0.35% | +1,015.42% | 42.17B | |
| +1.28% | -5.06% | -7.50% | -0.78% | +134.27% | +221.78% | +902.69% | +576.33% | - | 39.42B | |
| -0.74% | -4.84% | +6.31% | +6.19% | +9.41% | +14.53% | +44.45% | +3.10% | +154.40% | 32.71B | |
| -2.70% | -7.34% | -15.74% | +14.22% | +42.05% | +23.17% | +0.36% | -62.78% | - | 24.01B | |
| +1.11% | +15.18% | +30.19% | +57.08% | +47.85% | +60.27% | +49.33% | +3.20% | +162.43% | 26.5B | |
| +0.21% | -4.49% | -12.11% | -4.40% | -8.53% | -17.89% | -4.52% | -68.76% | - | 21.82B | |
| +1.79% | -0.62% | -19.20% | -9.21% | -45.37% | -42.03% | +298.16% | +260.15% | +590.99% | 20.38B | |
| -0.19% | +8.43% | +9.58% | +14.52% | +20.17% | +13.15% | +169.67% | +220.48% | +2,248.40% | 18.93B | |
| +0.42% | +13.43% | +21.46% | +59.53% | +79.37% | +83.23% | +107.32% | -16.80% | +367.85% | 17.06B | |
| -0.58% | +8.20% | +8.59% | +27.73% | +36.99% | +38.81% | +84.70% | -16.52% | +107.58% | 16.69B | |
| +0.35% | +1.52% | +11.99% | +17.13% | +49.14% | +63.47% | +223.61% | +206.90% | +498.63% | 16.13B | |
| +0.32% | +5.05% | +7.00% | -2.86% | - | - | - | - | - | 16.1B | |
| +2.59% | +1.28% | +3.03% | +4.85% | +180.86% | +162.43% | +375.61% | +1,411.75% | +779.81% | 14.75B | |
| -0.44% | +5.17% | +4.34% | +8.54% | +0.53% | +0.64% | -22.15% | -34.98% | +127.62% | 14.18B | |
| -5.62% | +0.27% | -2.96% | -11.83% | +15.55% | +3.56% | +512.43% | - | - | 14.63B | |
| Average | -0.26% | +3.99% | -0.17% | +9.99% | +35.63% | +35.97% | +188.93% | +145.36% | +854.49% | 27.76B | |
| Weighted average by Cap. | -0.47% | +2.92% | -0.12% | +12.60% | +36.62% | +39.21% | +165.03% | +122.52% | +1,230.07% |
- Stock Market
- Stocks
- NKTR Stock
- Sector Nektar Therapeutics
Select your edition
All financial news and data tailored to specific country editions
